A company focused on discovering membrane-permeable and orally available cyclic-peptides, taking a mission-driven approach.

INSAMO

Insamo

Please join Insamo CEO Tim Craven in a conversation about "Undruggable Targets and the Advent of Generative AI" at SynBioBeta 2024, happening on May 7th from 2:45 to 3:30 pm. We're diving deep into how generative AI is revolutionizing the hunt for new small molecule targets, especially those in previously inaccessible areas of biology. This session promises to be a fascinating exploration of the interface between advanced computing and biotechnology, showcasing how AI-driven approaches are opening doors to new therapeutic possibilities. We'll discuss the challenges, breakthroughs, and ethical considerations of using AI to navigate the complex landscape of 'undruggable' targets, highlighting the potential for significant medical advancements.

#SynBioBeta2024

#Artificialintelligence is bridging the gap between #syntheticbiology and #medicine - Meet the innovative #companies leading the way: GRO Biosciences, Absci, Generate:Biomedicines, Insamo, Arvinas, Atomwise, Exscientia, Collaborative Drug Discovery - CDD Vault, CellVoyant, Asimov, Alltrna, BioLoomics, Inc., BigHat Biosciences, LabGenius, Profluent Bio, Arzeda, Dreamfold, VantAI, Hexagon Bio, bitBiome, Inc., Enveda Biosciences: https://lnkd.in/gTjz9aEd #SynBioBeta2024 #synbio #AI Thank you to Jenna Gallegos

Metric
Company Name	INSAMO
Symbol
MSH ID	COM:INSAMO
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country
Stage
Employee Count	11
Website	insamo.com
LinkedIn	insamo
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	890
Web Traffic Growth	2.22
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

INSA

COM:INSAMO

INSAMO

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue